<DOC>
	<DOCNO>NCT02189629</DOCNO>
	<brief_summary>Multi-center , open-label , non-comparative safety efficacy study 52 Weeks treatment face trunk acne vulgaris .</brief_summary>
	<brief_title>CD5789 Long Term Safety Study Acne Vulgaris</brief_title>
	<detailed_description>To determine safety efficacy CD5789 50 Âµg/g cream long-term treatment ( 52 Weeks ) subject acne vulgaris . Efficacy evaluate secondary objective .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>The Subject facial acne severity grade IGA grade 3 ( moderate ) Screening Baseline visit . The Subject minimum 20 inflammatory lesion 25 noninflammatory lesion Screening Baseline visit face . The subject severe form acne ( acne conglobata , acne fulminans ) secondary acne form ( chloracne , druginduced acne , etc. ) . The Subject 1 nodule face Screening Baseline visit . The Subject acne cyst face Screening Baseline visit .</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Acne vulgaris</keyword>
	<keyword>Safety</keyword>
	<keyword>Face</keyword>
	<keyword>Trunk</keyword>
</DOC>